| T706 |
0-688 |
Sentence |
denotes |
Sperber, et al. (1995) [17] Randomized, double-blind, placebo-controlled clinical trial40 asymptomatic HIV-1 infected patients HCQ group - > 800 mg/dayControl group - > placebo8 weeks Total HIV-1 RNA plasma levelssignificantly decreased in the HCQ group (range, 98 to 2517 cpm; mean, 168 ± 144 cpm vs. 311 ± 331 cpm; p = 0.022).CD4+ T cells percentage remained stable in HCQ group (18.1 ± 9.2% before treatment vs. 18.6 ± 10.5% after treatment)Absolute CD4+ has not reported significant changes in both groupsIL-6 and IgG levels decrease in HCQ group (14.3 ± 13.5 U/mL vs. 12.0 f 16.7 U/mL; p = 0.023 and 2563 ± 1352 mg/mL vs. 2307 ± 1372 mg/dL; p = 0.032, respectively) Not reported. |
